PTH assays: Understanding what we have and forecasting what we will have

Journal of Osteoporosis

Volumn 2012, Issue , 2012, Pages

  Vieira, Jose Gilberto H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PARATHYROID HORMONE; PARATHYROID HORMONE[7-84]; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; AUTOMATION; CARBOXY TERMINAL SEQUENCE; ENZYME IMMUNOASSAY; HORMONE DETERMINATION; HUMAN; MASS SPECTROMETRY; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PURIFICATION; RADIOIMMUNOASSAY; REVIEW;

EID: 84876511851     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2012/523246     Document Type: Review

References (35)

1. Silverman R., Yalow R. S., Heterogeneity of parathyroid hormone. Clinical and physiologic implications. Journal of Clinical Investigation 1973 52 8 1958 1971 2-s2.0-0015847140
2. Habener J. F., Kemper B., Potts J. T., Calcium dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores. Endocrinology 1975 97 2 431 441 2-s2.0-0016784169
3. Vieira J. G. H., Kunii I. S., Ohe M. N., Carvalho A. B., Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease. Arquivos Brasileiros de Endocrinologia e Metabologia 2009 53 9 1074 1078 2-s2.0-77149148112
4. Divieti P., Inomata N., Chapin K., Singh R., Jüppner H., Bringhurst F. R., Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells. Endocrinology 2001 142 2 916 925 2-s2.0-0035103064 10.1210/en.142.2.916 (Pubitemid 32222442)
5. Divieti P., John M. R., Jüppner H., Bringhurst F. R., Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 2002 143 1 171 176 2-s2.0-0036142539 10.1210/en.143.1.171 (Pubitemid 34056416)
6. Divieti P., Geller A. I., Suliman G., Jüppner H., Bringhurst F. R., Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology 2005 146 4 1863 1870 2-s2.0-15444362814 10.1210/en.2004-1262 (Pubitemid 40396896)
7. Berson S. A., Yalow R. S., Aurbach G. D., Potts J. T. Jr., Immunoassay of bovine and human parathyroid hormone. Proceedings of the National Academy of Sciences of the United States of America 1963 49 613 616
8. Reiss E., Canterbury J. M., Egdahl R. H., Experience with a radioimmunoassay of parathyroid hormone in human sera. Transactions of the Association of American Physicians 1968 81 104 115 2-s2.0-0014391469
9. Arnaud C. D., Tsao H. S., Littledike T., Radioimmunoassay of human parathyroid hormone in serum. Journal of Clinical Investigation 1971 50 1 21 34 2-s2.0-0014985336
10. Brandão C. M., Kasamatsu T. S., Oliveira M. A., Vieira J. G., Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism. Brazilian Journal of Medical and Biological Research 1989 22 8 963 965 2-s2.0-0024803662
11. Zanella M. T., Silva M. C., Peres R. B., Ferreira S. R., Draibe S. A., Vieira J. G., Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure. Brazilian Journal of Medical and Biological Research 1990 23 3-4 235 243 2-s2.0-0025581927
12. Potts J. T. Jr., Tregear G. W., Keutmann H. T., Niall H. D., Sauer R., Deftos L. J., Dawson B. F., Hogan M. L., Aurbach G. D., Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proceedings of the National Academy of Sciences of the United States of America 1971 68 1 63 67 2-s2.0-0014983094
13. Desplan C., Jullienne A., Moukhtar M. S., Milhaud G., Sensitive assay for biologically active fragment of human parathyroid hormone. The Lancet 1977 2 8030 198 199 2-s2.0-0017412424 (Pubitemid 8143274)
14. Visser T. J., Buurman C. J., Birkenhager J. C., Immunological studies on parathyroid hormone: characterization of antisera against synthetic 1-34 human parathyroid hormone and evidence that position 30 in human parathyroid hormone is aspartic acid. Journal of Endocrinology 1977 74 3 461 466 2-s2.0-0017730230 (Pubitemid 8185886)
15. Atkinson M. J., Jüpnner H., Niepel B., Casaretto M., Zahn H., Hesch R.D., Characterization of binding sites of antiparathyroid hormone antisera using synthetic parathyroid hormone peptides. Journal of Immunoassay 1982 3 31 51 (Pubitemid 12026691)
16. Vieira J. G. H., Oliveira M. A. D., Maciel R. M. B., Development of an homologous radioimmunoassay for the synthetic amino terminal (1-34) fragment of human parathyroid hormone using egg yolk-obtained antibodies. Journal of Immunoassay 1986 7 1-2 57 72 2-s2.0-0022569988 (Pubitemid 16091332)
17. Vieira J. G., Oliveira M. A., Hidal J. T., Russo E. M., Chacra A. R., Critical analysis of 2 segment-specific radioimmunoassays for the measurement of parathyroid hormones in the diagnosis of primary hyperparathyroidism. Revista da Associacao Medica Brasileira 1988 34 3 79 83 2-s2.0-0024015605
18. Brandão C. M., Kasamatsu T. S., Oliveira M. A., Vieira J. G., Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism. Brazilian Journal of Medical and Biological Research 1989 22 8 963 965 2-s2.0-0024803662
19. Nussbaum S. R., Zahradnik R. J., Lavigne J. R., Brennan G. L., Nozawa-Ung K., Kim L. Y., Keutmann H. T., Wang C. A., Potts J. T., Segre G. V., Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clinical Chemistry 1987 33 8 1364 1367 2-s2.0-0023630019 (Pubitemid 18041971)
20. Vieira J. G., Nishida S. K., Kasamatsu T. S., Amarante E. C., Kunii I. S., Development and clinical application of an immunofluorometric assay for intact parathyroid hormone. Brazilian Journal of Medical and Biological Research 1994 27 10 2379 2382 2-s2.0-0028524720
21. Brossard J. H., Cloutier M., Roy L., Lepage R., Gascon-Barré M., D'Amour P., Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. Journal of Clinical Endocrinology and Metabolism 1996 81 11 3923 3929 2-s2.0-0029798288 10.1210/jc.81.11.3923 (Pubitemid 26380397)
22. Lepage R., Roy L., Brossard J. H., Rousseau L., Dorais C., Lazure C., D'Amour P., A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clinical Chemistry 1998 44 4 805 809 2-s2.0-0031901781 (Pubitemid 28176023)
23. Kunii I. S., Vieira J. G. H., Circulating forms of parathyroid hormone detected with an immunofluorometric assay in patients with primary hyperparathyroidism and in hyperparathyroidism secondary to chronic renal failure. Brazilian Journal of Medical and Biological Research 2001 34 12 1547 1550 2-s2.0-0035745774 (Pubitemid 34874037)
24. Silverberg S. J., Gao P., Brown I., Logerfo P., Cantor T. L., Bilezikian J. P., Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2003 88 10 4725 4730 2-s2.0-0242351809 10.1210/jc.2002-021266 (Pubitemid 37357518)
25. Boudou P., Ibrahim F., Cormier C., Chabas A., Sarfati E., Souberbielle J. C., Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2005 90 12 6370 6372 2-s2.0-28744435195 10.1210/jc.2005-0715 (Pubitemid 41759285)
26. Eastell R., Arnold A., Brandi M. L., Brown E. M., D'Amour P., Hanley D. A., Sudhaker Rao D., Rubin M. R., Goltzman D., Silverberg S. J., Marx S. J., Peacock M., Mosekilde L., Bouillon R., Lewiecki E. M., Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 2 340 350 2-s2.0-59749089672 10.1210/jc.2008-1758
27. Aloia J. F., Feuerman M., Yeh J. K., Reference range for serum parathyroid hormone. Endocrine Practice 2006 12 2 137 144 2-s2.0-33745333816
28. Rejnmark L., Vestergaard P., Heickendorff L., Mosekilde L., Determinants of plasma PTH and their implication for defining a reference interval. Clinical Endocrinology 2011 74 1 37 43 2-s2.0-78650324184 10.1111/j.1365-2265.2010.03894. x
29. Quarles L. D., Lobaugh B., Murphy G., Intact parathyroid hormoneover-estimates the presence and severity of parathyroid mediated osseous abnormalities in uremia. Journal of Clinical Endocrinology and Metabolism 1992 75 143 150
30. Coen G., Bonucci E., Ballanti P., Balducci A., Calabria S., Nicolai G. A., Fischer M. S., Lifrieri F., Manni M., Morosetti M., Moscaritolo E., Sardella D., PTH 1-84 and PTH 7-84 in the noninvasive diagnosis of renal bone disease. American Journal of Kidney Diseases 2002 40 2 348 354 2-s2.0-0036321071 10.1053/ajkd.2002.34519 (Pubitemid 34827653)
31. Mallette L. E., The parathyroid polyhormones: new concepts in the spectrum of peptide hormone action. Endocrine Reviews 1991 12 2 110 117 2-s2.0-0025904318
32. Rubin M. R., Silverberg S. J., D'Amour P., Brossard J. H., Rousseau L., Sliney J., Cantor T., Bilezikian J. P., An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma. Clinical Chemistry 2007 53 8 1470 1476 2-s2.0-34547626814 10.1373/clinchem.2007.085506 (Pubitemid 47206343)
33. Carvalho V. M., The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. Journal of Chromatography B 2012 883-884 50 58
34. Lopez M. F., Rezai T., Sarracino D. A., Prakash A., Krastins B., Athanas M., Singh R. J., Barnidge D. R., Oran P., Borges C., Nelson R. W., Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clinical Chemistry 2010 56 2 281 290 2-s2.0-75749115605 10.1373/clinchem.2009.137323
35. Kumar V., Barnidge D. R., Chen L. S., Twentyman J. M., Cradic K. W., Grebe S. K., Singh R. J., Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clinical Chemistry 2010 56 2 306 313 2-s2.0-75749111711 10.1373/clinchem.2009.134643